A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extracts

J Pharm Biomed Anal. 2012 Nov:70:378-87. doi: 10.1016/j.jpba.2012.05.035. Epub 2012 Jun 2.

Abstract

An assay using ultrahigh pressure liquid chromatography and mass spectrometry detection was developed and validated for measurement of the HIV integrase inhibitor raltegravir (MK-0518) in human cell extracts. The assay is designed to utilize 200 μl of 70% MeOH cell extract derived from human peripheral blood mononuclear cells or human tissue samples. The assay is linear over a range from 0.0023 to 9.2 ng ml(-1). The average %CV (SD/Mean)*100 and %deviation ((observed-target)/target)*100 were less than 20% at the lower limit of quantification and less than 15% over the range of the curve. This assay is an accurate and highly sensitive method for determining raltegravir concentrations in cellular extracts with a lower limit 40 to over 100-fold lower than other methods in the literature. We also present a new processing method where a rapid spin through oil produced a significant increase in apparent intracellular raltegravir concentration compared with conventional processing.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Validation Study

MeSH terms

  • Calibration
  • Cell Extracts
  • Centrifugation
  • Chromatography, High Pressure Liquid* / standards
  • Drug Stability
  • HIV Integrase Inhibitors / blood*
  • Humans
  • Leukocytes, Mononuclear / chemistry*
  • Limit of Detection
  • Linear Models
  • Methanol / chemistry
  • Pyrrolidinones / blood*
  • Raltegravir Potassium
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry* / standards

Substances

  • Cell Extracts
  • HIV Integrase Inhibitors
  • Pyrrolidinones
  • Raltegravir Potassium
  • Methanol